Sekretessinställningar
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Aktiemarknader
    • BörsRealtidskurser, index och marknadsutveckling
    • MorgonrapportDaglig marknadssammanfattning och nattens viktigaste händelser
    • BörskalenderKommande resultat, noteringar och företagshändelser
    • UtdelningskalenderKommande och tidigare utdelningar
  • Bolag
    • BolagBläddra och filtrera hela listan över noterade bolag
    • UpptäckInspiration till din nästa investering
    • BörsnoteringarNya noteringar och kommande börsintroduktioner
    • ÅrsstämmorDatum för årsstämmor och aktieägarinformation
  • Aktieforskning
    • AktieanalysExpertaktieanalys och rekommendationer
    • ArtiklarNyheter, insikter och marknadskommentarer
    • PortföljInderes modellportfölj
  • Lär dig om investeringar
    • AnalysskolaLär dig läsa och förstå aktieanalys
    • inderesTVVideohub för aktieanalys, forskning och expertkommentarer
    • TranskriptionerFullständiga utskrifter av resultatsamtal och investerarmöten
    • AktiejämförelseJämför nyckeltal och utveckling för flera aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • InsideraffärerFölj köp- och säljaktivitet hos företagsinsiders
    • BlankningSe vilka börsnoterade bolag som har offentliggjorda korta positioner
    • Virtuell analytikerchattStäll frågor och få AI-drivna investeringsinsikter direkt
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Q&A
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer

Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.

Magle Chemoswed Holding AB (publ) initiates a written procedure in order to utilise the option to pay PIK Interest under its super senior secured fixed rate bonds

Magle ChemoswedPressmeddelande2026-11-17 13:55

Magle Chemoswed Holding AB (publ) (the "Company") hereby announces that it, through Nordic Trustee & Agency AB (publ) as agent (the “Agent”) under its super senior secured fixed rate bonds with ISIN NO0013758086 (the "Bonds"), has initiated a written procedure (the "Written Procedure") in order to enable Bondholders to vote for or against the Company's request to utilise the PIK Component for the current Interest Period which ends on 1 December 2026 (with Interest Payment Date occurring on 2 December 2026).

Pursuant to the Terms and Conditions of the Bonds, the Company may elect to pay a part of the Interest under the Bonds as PIK Interest, subject to the Company giving prior notice of no less than 10 CSD Business Days' before the first day of the relevant Interest Period. For the current Interest Period the deadline for serving a notice to elect PIK Interest expired before the issuance of the Bonds and it was therefore not technically possible for the Company to elect the option to pay PIK Interest for the current Interest Period. It is against this background that the Company has initiated the Written Procedure.

 

Voting Information
 
To be eligible to participate in the Written Procedure, a person must be a holder of Bonds on 19 November 2026, meaning that the person must be registered on a securities account with Verdipapirsentralen ASA (Euronext Securities Oslo) as a direct registered owner or authorised nominee with respect to one or several Bonds.
 
The Agent must receive the voting form no later than 14:00 CET on 2 December 2026 either by mail, courier or email to the Agent using the contact details set out in Section 4.6 in the notice of the Written Procedure. Votes received thereafter may be disregarded.
 
For further information regarding the Written Procedure and the requests, including the full details of the proposal, please refer to the notice of Written Procedure available on the Company's website (https://maglegroup.com/) and via the Agent's information service Stamdata (https://stamdata.com/).

Contacts


Aaron Wong, CEO, phone +46 (0)76 664 35 79, aaron.wong@maglegroup.com

About Us


The Magle Group aims to establish itself as a leader in high-quality life-changing healthcare innovations to meet medical needs through scientific excellence. Today, the Group includes two operational areas. Magle Chemoswed – a contract manufacturing organization (CMO) with a strong reputation for its high-quality development and manufacturing expertise and Magle Biopolymers A/S - a specialized manufacturing organization of Dextran technology. Learn more on www.maglechemoswed.com and www.maglegroup.com and www.maglebiopolymers.com

Attachments


Magle Chemoswed Holding AB (publ) initiates a written procedure in order to utilise the option to pay PIK Interest under its super senior secured fixed rate bonds